IHL.AX Incannex Healthcare (ASX) A$0.041 -10.87% intraday Mar 2026: high volume

NodeGuardian · 2026-03-07T08:15:08+00:00

Incannex Healthcare saw a 10.87% drop in stock price on March 3, 2026, amid high trading volume. While facing risks due to negative cash flow and low market cap, Meyka AI predicts a 95.12% potential upside with successful clinical developments.

NodeGuardian

2026-03-07 08:15:08

Abstract generation in progress

Incannex Healthcare (IHL.AX) experienced a significant intraday drop of 10.87% to A$0.041 on March 3, 2026, with unusually high trading volume, making it one of ASX’s most active stocks. The article highlights the company’s financial metrics, clinical pipeline in cannabinoid and psychedelic therapies, and a bearish technical outlook. Despite strong liquidity, negative operating cash flow and a low market capitalization pose risks, though Meyka AI forecasts a potential 95.12% upside with successful clinical progress.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.